But we've been watching the GLP-1 space and just always thinking about what new effective treatments and solutions we can launch for our patients," Melynda Barnes, M.D., Ro's chief medical officer, said during an interview on the sidelines of the ViVE Conference in Nashville, Tennessee
Last reviewed: June 15, 2026 Last updated: June 15, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations
The post frames compounded tirzepatide's appeal as titration flexibility, letting a prescriber settle on a therapeutic level based on tolerability, biomarker changes and response over time
One study found that people with RA who started GLP-1 or SGLT2 medicine had fewer flares after starting treatment
Preproglucagon derived peptides GLP-1, GLP-2 and oxyntomodulin in the CNS: role of peripherally secreted and centrally produced peptides